Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C031903 |
1-UFT protocol |
IL17RB protein results in increased susceptibility to 1-UFT protocol | increases response to substance | 16734730
|
C063002 |
2,3-dimethoxy-1,4-naphthoquinone |
2,3-dimethoxy-1,4-naphthoquinone results in decreased expression of IL17RB mRNA | decreases expression | 17547211
|
C035207 |
4-amino-2,6-dinitrotoluene |
4-amino-2,6-dinitrotoluene affects the expression of IL17RB mRNA | affects expression | 21346803
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of IL17RB mRNA | increases expression | 20106945
|
C110904 |
capecitabine |
IL17RB protein results in increased susceptibility to capecitabine | increases response to substance | 16734730
|
D002857 |
Chromium |
Chromium results in decreased expression of IL17RB mRNA | decreases expression | 17547211
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of IL17RB mRNA | decreases expression | 20106945
|
D004128 |
Dimethylnitrosamine |
Dimethylnitrosamine results in decreased expression of IL17RB mRNA | decreases expression | 17547211
|
C025034 |
doxifluridine |
IL17RB protein results in increased susceptibility to doxifluridine | increases response to substance | 16734730
|
D008628 |
Mercury |
Mercury results in decreased expression of IL17RB mRNA | decreases expression | 17547211
|
D017239 |
Paclitaxel |
IL17RB protein results in decreased susceptibility to Paclitaxel | decreases response to substance | 16734730
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of IL17RB mRNA | affects binding|decreases expression|increases activity | 19710929
|
D011192 |
Potassium Dichromate |
Potassium Dichromate results in decreased expression of IL17RB mRNA | decreases expression | 17547211
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of IL17RB mRNA | increases expression | 20106945
|
D014303 |
Trinitrotoluene |
Trinitrotoluene affects the expression of IL17RB mRNA | affects expression | 21346803
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
4-amino-2,6-dinitrotoluene |
14.67 | 7525203 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
14.67 | 14514962 15322242 11752688 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Trinitrotoluene |
14.67 | 7525203 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.15 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
4.59 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Dimethylnitrosamine |
4.59 | 16033868 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
6.94 | 6695378 |
MESH:D000236 |
Adenoma |
|
Dimethylnitrosamine |
6.94 | 19555203 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
10.07 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
10.07 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.97 | 11748828 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.12 | 19183758 |
MESH:D001321 |
Autistic Disorder |
|
Mercury |
2.78 | 17497416 |
MESH:D001327 |
Autoimmune Diseases |
|
Mercury |
4.91 | 16634805 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.86 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.86 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.85 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.78 | 15746008 |
MESH:D001859 |
Bone Neoplasms |
|
Paclitaxel |
4.60 | 15867366 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.39 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
capecitabine |
2.39 | 18473752 12972520 |
MESH:D001943 |
Breast Neoplasms |
|
Chromium |
2.39 | 15986119 |
MESH:D001943 |
Breast Neoplasms |
|
Paclitaxel |
2.39 | 16244791 16115903 18323546 18234424 16273361 18223236 15136595 11325840 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.39 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Dimethylnitrosamine |
8.43 | 19555203 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
8.43 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Paclitaxel |
2.53 | 16313753 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.83 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Dimethylnitrosamine |
4.83 | 16033868 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.38 | 16120746 18670907 18850075 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Mercury |
3.46 | 10334427 |
MESH:D002386 |
Cataract |
|
4-amino-2,6-dinitrotoluene |
7.95 | 14694615 |
MESH:D002386 |
Cataract |
|
Trinitrotoluene |
7.95 | 14694615 15817613 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.54 | 12371664 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.19 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.83 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.83 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.11 | 16354765 8697196 12621046 15340226 15668235 |
MESH:D015179 |
Colorectal Neoplasms |
|
capecitabine |
3.25 | 18448328 18473752 |
MESH:D015179 |
Colorectal Neoplasms |
|
Paclitaxel |
3.25 | 18802399 |
MESH:D000013 |
Congenital Abnormalities |
|
4-amino-2,6-dinitrotoluene |
15.76 | 15095906 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
15.76 | 14669216 17141729 |
MESH:D000013 |
Congenital Abnormalities |
|
Trinitrotoluene |
15.76 | 15095906 |
MESH:D003329 |
Coronary Vasospasm |
|
capecitabine |
5.84 | 17465463 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.25 | 10048152 15322242 20055451 |
MESH:D003490 |
Cyanosis |
|
Trinitrotoluene |
4.96 | 18551238 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Mercury |
7.88 | 16823706 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Potassium Dichromate |
7.88 | 16823706 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.44 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.67 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4-amino-2,6-dinitrotoluene |
9.14 | 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Dimethylnitrosamine |
9.14 | 8172417 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
9.14 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Trinitrotoluene |
9.14 | 18551238 21346803 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.78 | 11462148 |
MESH:D004487 |
Edema |
|
pirinixic acid |
6.63 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.63 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.96 | 18230668 15322242 16714409 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.05 | 9294722 10568697 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
7.44 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Dimethylnitrosamine |
7.44 | 17016578 |
MESH:D004938 |
Esophageal Neoplasms |
|
Paclitaxel |
7.44 | 16481741 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.03 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
7.66 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
7.66 | 19236843 20131406 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.50 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.62 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.62 | 20067830 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.27 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.66 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.49 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.49 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.55 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.47 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.36 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
14.74 | 16221962 18467677 19772884 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
14.74 | 15340226 12621046 16120746 |
MESH:D006529 |
Hepatomegaly |
|
Trinitrotoluene |
14.74 | 15817613 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.11 | 15340226 16959395 8697196 18606429 16354765 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.21 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.98 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.98 | 18670907 18850075 |
MESH:D007248 |
Infertility, Male |
|
Trinitrotoluene |
3.69 | 12150543 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.87 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.65 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.36 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.50 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Chromium |
14.74 | 17934191 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
14.74 | 10903974 8314463 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Mercury |
14.74 | 17934191 |
MESH:D007674 |
Kidney Diseases |
|
Potassium Dichromate |
14.74 | 19665454 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.76 | 12371664 |
MESH:D008080 |
Liposarcoma |
|
Paclitaxel |
4.85 | 17353645 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dimethylnitrosamine |
3.50 | 17198567 18364076 15383259 15298665 17201889 17036385 16570917 17719030 16603200 17881167 14726149 18237412 18567088 17465448 17203207 17348192 15577212 15086199 17534399 15081153 15571005 18672772 15161499 15366600 15591649 15339415 14643895 18095165 15369754 14709902 15793283 17666798 15723089 15067225 15744066 14659978 18239293 17640959 15504291 12918455 16169303 16042886 16009107 15763062 18637143 15138612 18629640 15864749 17724770 17432682 15798949 15479170 14568256 16270385 16627068 15842777 17196135 15099470 15942678 15733078 16544323 15492853 18210741 18371158 12925901 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.50 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.50 | 12878042 |
MESH:D017114 |
Liver Failure, Acute |
|
Dimethylnitrosamine |
4.43 | 17457977 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
10.78 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Dimethylnitrosamine |
10.78 | 15890375 3113478 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
10.78 | 16377806 20007298 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
10.78 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Dimethylnitrosamine |
6.08 | 1848544 15603536 6150874 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.08 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
3.46 | 6695378 18816296 17053015 20464547 20135361 18569708 20869020 18520028 20064080 |
MESH:D008175 |
Lung Neoplasms |
|
Dimethylnitrosamine |
3.46 | 16061637 11884234 19555203 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.46 | 11884234 19555203 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Paclitaxel |
4.11 | 14749477 |
MESH:D008545 |
Melanoma |
|
Paclitaxel |
2.59 | 12040289 12025231 16342250 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.85 | 16801185 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.21 | 16381670 |
MESH:D009101 |
Multiple Myeloma |
|
Paclitaxel |
3.71 | 14749477 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.55 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.15 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.04 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.97 | 16411023 |
MESH:D009336 |
Necrosis |
|
Trinitrotoluene |
4.82 | 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
capecitabine |
6.60 | 12972520 |
MESH:D009362 |
Neoplasm Metastasis |
|
Paclitaxel |
6.60 | 15867366 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
8.47 | 11141357 |
MESH:D009369 |
Neoplasms |
|
capecitabine |
8.47 | 16374040 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
8.47 | 17405874 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.50 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.31 | 18481113 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.25 | 14600291 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.82 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
4-amino-2,6-dinitrotoluene |
9.55 | 14694615 |
MESH:D009784 |
Occupational Diseases |
|
Trinitrotoluene |
9.55 | 14694615 12819281 17852074 |
MESH:D010014 |
Osteolysis |
|
Paclitaxel |
5.03 | 15867366 |
MESH:D010051 |
Ovarian Neoplasms |
|
Paclitaxel |
3.00 | 11161223 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.31 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.59 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.25 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.24 | 11896295 11222880 11399792 11118676 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.39 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Paclitaxel |
3.39 | 17136230 17172428 16729912 16356831 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.24 | 16882103 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.40 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.87 | 18990726 |
MESH:D012640 |
Seizures |
|
Trinitrotoluene |
3.46 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
5.51 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.51 | 16192470 |
MESH:D013158 |
Splenic Diseases |
|
Dimethylnitrosamine |
5.33 | 12587719 |
MESH:D013163 |
Splenomegaly |
|
Trinitrotoluene |
5.24 | 15817613 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
3.52 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
Dimethylnitrosamine |
3.52 | 16033868 |
MESH:D013274 |
Stomach Neoplasms |
|
Paclitaxel |
3.52 | 18396642 18506536 |
MESH:D024801 |
Tauopathies |
|
Paclitaxel |
4.86 | 16930453 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.96 | 12697716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
2.19 | 17053015 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.05 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.66 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.31 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.50 | 17120751 |